Welcome, we are proud to present the first Transplant and Dialysis Access Symposium in honor of Dr. John C. McDon-ald, MD (1930-2011). Recognized as a pio-neer in the field of or-gan transplantation, Dr. McDonald was Chancellor Emeritus of the Louisiana State University Health Sci-ences Center and former Dean of the LSU School of Medicine. He also served as the Chairman of the Department of Surgery from 1977-2000. Under his guidance, the first kidney transplant was performed at LSU Medical Center in April 1976. Since then, our transplant team has performed more than 2000 kidney, pancreas and liver transplants in Shreveport, LA. We are indebted to Dr. McDonald for his years of contibution and service to transplant recipients from Louisiana, Texas, Arkansas and Mississippi. The goal of this symopsium is to educate the health care professionals regarding new developments and complex issues in the management of dialysis and transplant patients. We hope that you can join us for our inaugural Transplant and Dialysis Acccess Symosium on No-vember 1st in Shreveport, LA.
|Time||Events||Name||Events [ Link ]|
|7.30 - 8.15 am||REGISTRATION, BREAKFAST AND EXHIBITS|
|8.15 - 8.20 am||WELCOME AND OVERVIEW|
|8.20 -10.00 am SESSION I||WHATS NEW & WHATS HOT IN TRANSPLANT?MODERATORS:||Kenneth Abreo MD|
|Gazi B. Zibari MD|
|8.20 - 8.40 am||Organ Shortage and Allocation||Gazi B. Zibari MD||Click Here|
|8.40 - 9.00 am||Newer Immunosuppression||Neeraj Singh MD||Click Here|
|9.00 - 9.20 am||Living Kidney Donation and Outcomes||Kenneth Abreo MD||Click Here|
|9.20 - 9.40 am||Economics of Kidney Transplant||Janea Matherly RN||Click Here|
|9.40 -10.00 am||Pancreas Transplant for Type II Diabetes Mellitus||Hosein Shoukouh Amiri MD||Click Here|
|10.00 - 10.20 am||BREAK AND EXHIBITS|
|10.20 - 12.00 am SESSION II||DIALYSIS ACCESS ISSUES IN ESRD PATIENTS MODERATORS:||Raja Zabaneh MD|
|Joan Blondin MD|
|10.20 - 10.40 am||When Should I Get an AVF for My CKD Patient?||Karina Sulaiman MD||Click Here|
|10.40 - 11.00 am||Pre surgical Evaluation for Dialysis Access and Outcomes||Hosein Shoukouh Amiri MD||Click Here|
|11.00 - 11.20 am||Urgent Start Peritoneal Dialysis||Bharat Sachdeva MD||Click Here|
|11.20 - 11.40 am||AV Access When There Are Minimal Options||Amy Coulter MD||Click Here|
|11.40 - 12:00 pm||Non Infectious Complications of Peritoneal Dialysis||Mary Buffington MD||Click Here|
|12.00 - 1.00 pm||LUNCH AND EXHIBITS|
|1.00 - 3.20 pm SESSION III:||CONTOVERSIES IN TRANSPLANT AND DIALYSIS ACCESS MODERATORS:||Randal White MD DIALYSIS|
|Hosein Shoukouh Amiri MD|
|1.00 -1.20 pm||When Is Access Flow Too High and What To Do About It?||Adrian Sequeira MD||Click Here|
|1.20 -1.40 pm||Thigh Grafts. Are They A Viable Access?||Gazi B. Zibari MD||Click Here|
|1.40 - 2.00 pm||Dialysis Access Surveillance: Medical Directors Perspective.||Michael D Rokaw MD||Click Here|
|2.00 - 2.20 pm||Do Stents Have A Role In Vascular Access?||Tze-Woei Tan MD||Click Here|
|2.20 - 2.40 pm||Is Parathyroidectomy Helpful Post Kidney Transplant?||Donnie F. Aultman MD||Click Here|
|2.40 - 3:00 pm||Liver Transplant For Malignancy||Robert McMillian MD||Click Here|
|3.00 - 3.30 pm||BREAK AND EXHIBITS|
|3.30 - 5.00 pm SESSION IV||CASE BASED DISCUSSION MODERATORS||Bharat Sachdeva MD|
|Robert Mcmillan MD|
|3.30 - 3.45 pm||A Kidney Transplant Recipient With Hypertension. What Are Some Of The Key Issues In Management?||Zulqarnain Abro MD||Click Here|
|3.45 - 4.00 pm||A Kidney Transplant Recipient with a Cancer. What Is the Role of Cancer Screening Post-Transplant?||Robert Nickelson MD||Click Here|
|4.00 - 4.15 pm||Recurrent Hepatitis C After Liver Transplant. How Do We Treat?||David Dies MD||Click Here|
|4.15 - 4.30 pm||Role Of Vascular Access Coordinator: Do we really need one?||Keri Lee RN||Click Here|
|4.30 - 4.45 pm||Recurrent AVG Thrombosis. Is Anticoagulation Required?||Neville Dossabhoy MD||Click Here|
|4.45 - 5.00 pm||Q&A|
- Analyze new developments and controversial issues in kidney transplant.
- Discuss the therapeutic strategies in patients with complex kidney Transplant issues
- Analyze the importance of vascular access in end-stage renal disease.
- Discuss creation and maintainaince for optimal performance of vascular access
The course is designed to help healthcare pro-viders caring for patients with solid abdominal organ transplants and end stage renal disease, including but not limited to transplant surgeons and physicians, nephrologists, physician assistants, nurses, nurse prac-tioners, and fellows.
CME ACCREDITATION & CREDIT DESIGNATION
- Louisiana State University Health Sciences Center-Shreve-port, School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
- Louisiana State University Health Sciences Center-Shreve-port, School of Medicine designates this live activity for a maximum of 7.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
7.0 contact hours of continuing education credit will be awarded to Registrered Nurses upon successful completion of this offering.
University Health Shreveport is an approved provider of continuing nursing education by the South Central Accreditation Program, an accredited approver by the American Nurses credentialing Center’s Commission on Accreditation.